Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals to Present at the Susquehanna SIGnificant Options in Healthcare Conference
March 14th, 2008
Anadys Pharmaceuticals, Inc. (NASDAQ:ANDS) announced that it will present at the Susquehanna Second Annual SIGnificant Options in Healthcare Conference on Tuesday, March 4, 2008 at 4:30 p.m. EST (1:30 p.m. PST). The conference is being held at the W Hotel in New York. Steve Worland, Ph.D., President and Chief Executive Officer of Anadys Pharmaceuticals, Inc., will present an overview of Anadys and its two development-stage product candidates, ANA598 and ANA773. Additionally, Dr. Worland will participate as a panel member in a discussion of the role of non-nucleoside and nucleoside polymerase inhibitors in the future of HCV therapy at the conference...
Source: Health Business Week (2008-03-14)
|
